BusinessARCA Biopharma announces first quarter 2018 financial results AND Provides Corporate UpdateBy Nasdaq OMXMay 8, 2018, 8:15 PM UTC
BusinessNew Data Showing Patient Care Individualized by Daxor’s Precision Blood Volume Analysis Reduces Heart Failure Readmissions by 56% and Mortality by over 80% Presented at the American College of Cardiology 2018 Annual Scientific SessionBy Nasdaq OMXMar 14, 2018, 12:01 PM UTC
BusinessMyoKardia Begins Patient Dosing in Phase 1b Clinical Study of MYK-491 in Dilated Cardiomyopathy PatientsBy Nasdaq OMXFeb 14, 2018, 1:30 PM UTC
BusinessCHF Solutions, Inc. to Present at the LD Micro 10th Annual Main Event on December 5, 2017By Nasdaq OMXNov 30, 2017, 12:15 PM UTC
BusinessCHF Solutions, Inc. Announces Pricing of $18.0 Million Underwritten Public OfferingBy Nasdaq OMXNov 22, 2017, 1:30 PM UTC
BusinessARCA Biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic TargetingBy Nasdaq OMXNov 16, 2017, 1:30 PM UTC
BusinessCHF Solutions’ Aquadex FlexFlow® Aquapheresis System Receives FDA IDE Approval for Clinical Study for Pediatric UseBy Nasdaq OMXJun 29, 2017, 11:00 AM UTC
BusinessARCA Biopharma Announces Database Lock for GENETIC-AF Phase 2B Interim Efficacy Analysis – DSMB Recommendation Anticipated in August 2017By Nasdaq OMXJun 20, 2017, 12:30 PM UTC
